Personalized Medicine News and Research

RSS

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

Prostate cancer stands as a prevalent threat to men's health, ranking second in cancer-related deaths in the United States.

11 Mar 2024

MGI Tech and Eurofins genomics partner to elevate precision health with revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

MGI Tech, a company committed to building core tools and technology to lead life science, today proudly announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S (“Eurofins Genomics”), which has placed a corporate order of the revolutionary DNBSEQ-T20×2 (“T20”) ultra-high throughput sequencer, along with the genomics data center ZTRON Appliance and a range of MGI’s state-of-the-art laboratory automation products and systems.

From MGI 6 Mar 2024

Harvard's Catherine Brownstein's Multi-Omics Approach: A New Horizon for Understanding Rare Pediatric Disorders

Catherine Brownstein, MPH, PhD, an esteemed Assistant Professor at Harvard Medical School and an investigator at Boston Children's Hospital.

From Society for Laboratory Automation and Screening (SLAS) 6 Mar 2024

European initiative aims to advance the understanding of RNA communication

RNA, which stands for ribonucleic acid has become a mainstream word in society due to the COVID-19 RNA vaccine - yet the value of this biomolecule to society could extend to numerous sectors including food security and personalized medicine.

5 Mar 2024

AI and predictive medicine: Recent advances

The potential of deep learning (DL) in enhancing predictive modeling for omics data analysis.

4 Mar 2024

Microbial signatures linked to immunotherapy response across cancers

The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynecological cancers, biliary tract cancers and melanoma.

1 Mar 2024

Genetic studies shed light on hypertension risk but fall short of revealing new treatments

Genetic variant research in hypertension has identified numerous associations but is unlikely to yield new treatments, emphasizing the gap between scientific discovery and clinical application.

27 Feb 2024

Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Despite considerable life-saving progress, cardiovascular diseases (CVDs) remain the leading cause of death globally, claiming an estimated 17.9 million lives each year.

26 Feb 2024

Digital DNA melting analysis can be a faster and more reliable tool for pathogen detection

A new analysis method can detect pathogens in blood samples faster and more accurately than blood cultures, which are the current state of the art for infection diagnosis.

21 Feb 2024

Unlocking the brain's decision-making secrets for future insights

Researchers at Washington University School of Medicine in St. Louis have found important clues to how people make choices involving obtaining information about the future.

16 Feb 2024

Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect gene fusions in cancer diagnostics and its pivotal role in advancing personalized oncology treatments.

From Aventa Genomics 16 Feb 2024

Insights into how AI and wearable technologies are impacting the future of healthcare

Imagine a world in which the digital watch on your wrist tracks not only your step count, but also your blood sugar, heart rate, blood pressure and respiration.

14 Feb 2024

New AI-powered protein mapping tool optimizes cancer therapy

Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumour, enabling clinicians to decide how to target treatment in a more precise way.

13 Feb 2024

Researchers develop groundbreaking technique to detect chemoresistance using ultrasound

Researchers at Purdue University have developed a technique to better predict chemotherapy resistance in canines and humans.

13 Feb 2024

Novel assay enhances pediatric cancer treatment by identifying clinically relevant gene fusions

Identification of specific gene fusions is critical for the successful targeted treatment of pediatric cancer patients.

13 Feb 2024

Understanding how natural genetic variation contributes to adaptive responses to low oxygen

Humans are still evolving, and Tatum Simonson, PhD, founder and co-director of the Center for Physiological Genomics of Low Oxygen at University of California School of Medicine, plans to use evolution to improve healthcare for all.

12 Feb 2024

Tiny device could help improve safety, effectiveness of cell therapy for spinal cord injury patients

A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.

7 Feb 2024

Personalized medicine offers hope for millions with inflammatory bowel disease

The prevalence of inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is rapidly increasing worldwide, affecting an estimated 6.8 million people.

6 Feb 2024

NIH awards $1.9 million to investigate how complex communities of microbes impact human health

The bacteria and microorganisms that live within the human body - the microbiota - can impact human health, disease risk and even how the body absorbs medications, but the details of these processes are unclear.

5 Feb 2024

Tecan offers end-to-end solutions for cellomics: automated workflows from single-cell dispensing to 3D spheroid analysis

Tecan is proud to offer end-to-end cellomics workflow solutions, including cell seeding and culture with quality control and monitoring, through drug dosing to live-cell imaging and analysis. This comprehensive offering enables laboratories to improve the reliability, reproducibility and throughput of their workflows, addressing key challenges in the growing field of 3D cell biology.

5 Feb 2024

Personalized Medicine News and Research

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

MGI Tech and Eurofins genomics partner to elevate precision health with revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

Harvard's Catherine Brownstein's Multi-Omics Approach: A New Horizon for Understanding Rare Pediatric Disorders

European initiative aims to advance the understanding of RNA communication

AI and predictive medicine: Recent advances

Microbial signatures linked to immunotherapy response across cancers

Genetic studies shed light on hypertension risk but fall short of revealing new treatments

Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Digital DNA melting analysis can be a faster and more reliable tool for pathogen detection

Unlocking the brain's decision-making secrets for future insights

Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing

Insights into how AI and wearable technologies are impacting the future of healthcare

New AI-powered protein mapping tool optimizes cancer therapy

Researchers develop groundbreaking technique to detect chemoresistance using ultrasound

Novel assay enhances pediatric cancer treatment by identifying clinically relevant gene fusions

Understanding how natural genetic variation contributes to adaptive responses to low oxygen

Tiny device could help improve safety, effectiveness of cell therapy for spinal cord injury patients

Personalized medicine offers hope for millions with inflammatory bowel disease

NIH awards $1.9 million to investigate how complex communities of microbes impact human health

Tecan offers end-to-end solutions for cellomics: automated workflows from single-cell dispensing to 3D spheroid analysis

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News